NUMD

Nu-Med Plus, Inc. NUMD

NUMD
Nu-Med Plus, Inc. CYDX
CYduct Diagnostics, Inc. TLIS
Talis Biomedical Corporation USAQ
QHSLab, Inc. MODVQ
ModivCare Inc. SLDX
Stella Diagnostics Inc. ZLDAF
Zelira Therapeutics Limited PLSH
Panacea Life Sciences Holdings, Inc. ECIA
Encision Inc. TBRIF
Therma Bright Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NUMD CYDX TLIS USAQ MODVQ SLDX ZLDAF PLSH ECIA TBRIF
6M -55.43 % -1.04 % -5.63 % 40.60 % -92.93 % -66.12 % -19.08 % 91.26 % -40.00 % -54.57 %
YTD 103.26 % 31.49 % -11.18 % -19.94 % -99.43 % -61.40 % -36.66 % 180.00 % -49.33 % -75.27 %
1Y -28.11 % 42.65 % -10.65 % 23.92 % -99.51 % -60.48 % -52.23 % -12.50 % -51.49 % -80.38 %
3Y 20.00 % -50.26 % -85.06 % 33.76 % -99.92 % -83.20 % -71.46 % -14.63 % -49.33 % -83.74 %
5Y -96.88 % -75.00 % -99.64 % -67.84 % -99.94 % -98.27 % -97.69 % -90.00 % -50.43 % -91.99 %
10Y -94.80 % -96.00 % -99.64 % 7.75 % -99.86 % -98.27 % -96.53 % -90.00 % -54.40 % -74.98 %
From the beginning -95.84 % -100.00 % -99.64 % -13.80 % -99.49 % -98.27 % -96.53 % -90.00 % -92.27 % -74.98 %

Dividend